U.S. Food And Drug Administration (fda)
Recent News About U.S. Food And Drug Administration (fda)
-
Investors say biopharmaceutical company violated Securities Exchange Act
PHILADELPHIA — Investors have filed a class-action lawsuit against Trevena Inc., Maxine Gowen and Roberto Cuca, a biopharmaceutical company and officials, alleging violation of the Securities Exchange Act. -
Bad Science at NIOSH?
The National Institute for Occupational Safety and Health (NIOSH) was established by the Occupational Safety and Health Act of 1970 as a research agency focused on the study of worker safety and health. -
Underwriting important for insurance policies in product contamination claims
PITTSBURGH – A Pennsylvania federal court made a ruling this year using New York law determining that an insurer could rescind its product contamination policy because of an insured’s material misrepresentations made during the application process concerning its loss history. -
Risperdal litigation parties scheduled to meet in September at Philadelphia Court of Common Pleas
Parties involved in the consolidated Pennsylvania litigation involving the drug Risperdal will convene on Sept. 16 at 2 p.m. at the Philadelphia Court of Common Pleas to discuss claims filed against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc.